Evidence map›Paper›PMID 33271210›Full record

SynthesisProgress in neuro-psychopharmacology & biological psychiatry2021

A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders.

Anna N Ligezka, A Irem Sonmez, Martha P Corral-Frias, Raphael Golebiowski, Brian Lynch, Paul E Croarkin, Magdalena Romanowicz

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Progress in neuro-psychopharmacology & biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Add-OnNutrients · 2024
    Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Anna N LigezkaDepartment of Psychiatry and Psychology Mayo Clinic, Rochester, MN, United States of America.
A Irem SonmezDepartment of Psychiatry and Psychology Mayo Clinic, Rochester, MN, United States of America.
Martha P Corral-FriasUniversidad Autónoma de Nuevo León, School of Medicine and University Hospital "Dr. José Eleuterio González", Psychiatry Department, Monterrey, Mexico.
Raphael GolebiowskiDepartment of Psychiatry and Psychology Mayo Clinic, Rochester, MN, United States of America.
Brian LynchDepartment of Pediatric and Adolescent Medicine Mayo Clinic, Rochester, MN, United States of America.
Paul E CroarkinDepartment of Psychiatry and Psychology Mayo Clinic, Rochester, MN, United States of America.
Magdalena RomanowiczDepartment of Psychiatry and Psychology Mayo Clinic, Rochester, MN, United States of America. Electronic address: romanowicz.magdalena@mayo.edu.
Mayo Clinic in Florida · USUniversidad Autónoma de Nuevo León · MX

Funding

Glutamatergic and GABAergic Biomarkers in rTMS for Adolescent DepressionR01MH113700 · NIMH · MAYO CLINIC ROCHESTER · PI CROARKIN, PAUL E · 2017 to 2021
$2.5M
A Randomized Controlled Trial of Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents with Suicidal Ideation Associated with Major Depressive DisorderR01MH124655 · NIMH · MAYO CLINIC ROCHESTER · PI CROARKIN, PAUL E · 2020 to 2023
$2.4M
NIMH NIH HHS R01 MH113700NIMH NIH HHS R01 MH124655
6 · The paper itself

Abstract

objectivesIn recent decades, the diagnostic and therapeutic implications of the microbiome changes and the impact of probiotic supplementation have increased rapidly. However, the potential for clinical translation of microbiome research for children and adolescents with psychiatric disorders is unclear. This review examined available evidence related to gut microbiota as well as the impact of probiotic supplementation on psychiatric disorders in the pediatric population reported to date.

methodsWe performed a literature search for the gut microbiota in child and adolescent population (0-18 years old) with mental health disorders from July 1999 through July 2019 in several databases: ClinicalTrials.gov, Ovid EBM Reviews, Ovid Embase, Ovid Medline, Ovid PsycINFO, Scopus, and Web of Science.

resultsA total of 7 studies met inclusion criteria consisting of randomized controlled trials and cohort studies that examined various associations between psychiatric disorders and gut microbiota in youth. Six studies examined the effects of various treatment interventions such as probiotic supplementation on microbiota composition and behaviors. One study showed an increase in prosocial behavior in children with Autism Spectrum Disorder (ASD) and an increase in the Lachnospiraceae family following prebiotic supplementation. Another study suggested that prebiotic supplementation increased bifidobacterial populations for ASD and healthy controls. A study evaluating infant supplementation of prebiotics showed both a decreased likelihood of developing Attention Deficit Hyperactivity Disorder (ADHD) or ASD and decreased gut Bifidobacterium. One study did not find significant differences in microbiome composition after micronutrient treatment.

conclusionThe main goal of this systematic review was to comprehensively examine and summarize the current evidence focused on the potential effect of the relationship between microbiota gut composition as well as the effects of probiotic supplementation on psychiatric disorders in children and adolescents. This is a relatively new area of research and the number of included studies is limited. More studies are needed to determine whether gut dysbiosis leads to the development and/or contributes to the severity of mental disorders or whether gut dysbiosis is a result of other processes that accompany mental disorders. CLINICAL SIGNIFICANCE: A better understanding of the specific bacteria contributions, gut-brain pathways, and role in pathophysiological mechanisms in neuropsychiatric disorders in the child and adolescent populations can possibly provide alternative tools for a clinical psychiatrist. Moreover, it may ultimately aid the clinician with intervention strategies, or detect populations at risk for developing neuropsychiatric disorders.

Indexed as

AdolescentBrain-Gut AxisChildGastrointestinal MicrobiomeHumansMental DisordersProbioticsADHDAnxietyAutismChildrenDepressionGut microbiotaInfantsMental healthNeuropsychiatric disorderPhobiaProbiotic supplementationTeenagersYoung adults

Identifiers

PMID33271210
PMCPMC8138744
OpenAlexW3107723516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.